Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3

Molecular Therapy

Volumn 5, Issue 6, 2002, Pages 705-715

  Ahonen, Matti ^a   Ala Aho, Risto ^a   Baker, Andrew H ^b   George, Sarah J ^c   Grénman, Reidar ^d   Saarialho Kere, Ulpu ^e   Kähäri, Veli Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adenovirus; Matrix metalloproteinase; Melanoma; Squamous cell carcinoma; Tissue inhibitor of metalloproteinase

Indexed keywords

ADENOVIRUS VECTOR; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE 3; ANTINEOPLASTIC AGENT; METALLOPROTEINASE; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CELL COUNT; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG POTENCY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; CANCER TRANSPLANTATION; DRUG ANTAGONISM; GENE VECTOR; GENETICS; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY);

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BYSTANDER EFFECT; CARCINOMA, SQUAMOUS CELL; GENE THERAPY; GENETIC VECTORS; HUMANS; MELANOMA; METALLOENDOPEPTIDASES; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035988999     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0606     Document Type: Article

References (47)

1. Regulation of matrix metalloproteinase expression in tumor invasion
2. Matrix metalloproteinases in human melanoma
3. Collagenase immunolocalization studies of cutaneous secondary melanomas
4. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
5. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMM-PRIN in benign and malignant pigment cell lesions of the skin
6. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas
7. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
8. High collagenase-1 expression correlates to favourable chemoimmunotherapy response in human metastatic melanoma
9. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family
10. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
11. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix
12. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
13. TNF-α converting enzyme (TACE) is inhibited by TIMP-3
14. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3
15. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5)
16. TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells
17. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
18. Human myeloma cells shed the interleukin-6 receptor: Inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor
19. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes
20. Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type 1 α2 (COL1A2) are epidermal growth factor-regulated growth repressors
21. Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells
22. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
23. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers
24. Hypermethylation of multiple genes in pancreatic adenocarcinoma
25. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3
26. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis
27. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
28. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
29. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo
30. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion
31. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4
32. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells
33. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
34. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
35. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
36. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers
37. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck
38. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells
39. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis
40. Localisation of the death domain of TIMP-3 to the N-terminus: Metalloproteinase inhibition is associated with pro-apoptotic activity
41. Induction of apoptosis in melanoma cell lines by p53 and its related proteins
42. Recent advances in melanoma staging and therapy
43. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
44. Development of recombinant adenoviruses that drive high-level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection and human MCF-7 adenocarcinoma cells
45. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis
46. Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FIRE, a growth factor-inducible element
47. Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression